Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 5 Anus Neoplasms 5 Non-Muscle Invasive Bladder Neoplasms 3 Carcinoma, Transitional Cell 3 Rectal Neoplasms 1 Locally Advanced Anal Canal Cancer 1 HIV Infections 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Appendiceal Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Paclitaxel 62 Letrozole 55 Fulvestrant 55 Trastuzumab 50 palbociclib 41 pembrolizumab 37 Cyclophosphamide 37 Carboplatin 37 Anastrozole 37 pertuzumab 35 exemestane 25 Tamoxifen 24 Capecitabine 24 ribociclib 23 abemaciclib 23 Radiotherapy 21 Docetaxel 21 olaparib 20 Doxorubicin 20 Magnetic Resonance Spectroscopy 19 trastuzumab deruxtecan 17 Surveys and Questionnaires 17 durvalumab 16 Epirubicin 16 Specimen Handling 14 Exercise 14 130-nm albumin-bound paclitaxel 14 Taxes 13 Alpelisib 13 Goserelin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Neoplasms × Mitomycin × Clear all

NCT02299999 2025-01-15

SAFIR02_Breast

UNICANCER

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡